Global /United States /Healthcare /Drug Manufacturers - General /TKNO
chevron_leftBack
Alpha Teknova, Inc. logo

Alpha Teknova, Inc.

TKNO
NASDAQ: TKNO Delayed
3.24USD -0.9%
As of 14 June 2026, Alpha Teknova, Inc. has a market cap of $173.7M USD, ranking #21950 globally and #3548 in the United States. It ranks #1973 in the Healthcare sector, and #711 in the Drug Manufacturers - General industry.
Global Rank
21950
Country Rank
3548
Sector Rank
1973
Industry Rank
711
Key Stats
Market Cap
$173.7MUSD
Enterprise Value
$179.29MUSD
Revenue (TTM)
$40.52MUSD
EBITDA (TTM)
-$10.13MUSD
Net Income (TTM)
-$17.26MUSD
EBITDA Margin
-25%
Profit Margin
-43%
PS Ratio
4.3
PB Ratio
2.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Stephen Gunstream open_in_new
Employees
158
Founded
1996
IPO
25 Jun 2021
Website
teknova.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.9% 2.9% 19% 8.4% -40% -52%

News

Loading...

TKNO Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
TKNO
Alpha Teknova Inc
ISIN: US02080L1026
Shares Out.:
53.614M1 Shares Float: 10.851M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
3.24 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Alpha Teknova, Inc.

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company’ primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Similar Companies

Industry: Drug Manufacturers - General (United States)
Name
Market Cap diff.
PE
LLY
$761.68B
438K%
38.1
JNJ
$547.28B
315K%
26.4
ABBV
$360.63B
208K%
97.4
MRK
$274.03B
158K%
15.1
PFE
$149.38B
86K%
19.5
$117.58B
68K%
16.8
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
$321.52B
256.25B CHF
185K%
19.9
AZN
$288.84B
215.59B GBP
166K%
27.6
NOVN
$274.65B
218.9B CHF
158K%
20.5
NOVO-B
$181.82B
1.18T DKK
105K%
11.5
SAN
$110.1B
95.26B EUR
63K%
19.9
GSK
$108.46B
80.96B GBP
62K%
14.6
chevron_leftBack